entertainment -WSS

entertainment

author：explore 2025-09-30 12:18:45 - browse：61

A masked person wears Onward Medical’s non-invasive spinal cord stimulator, solving a Rubik's cube — health tech coverage from STAT — Courtesy Onward Medical

After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.

So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal. It was late 2021, and Campbell was nearing the end of a clinical trial testing out a device to help paralyzed patients regain movement.

“I felt really refreshed and excited, because you get to this point where normally I’d have to back off or monitor if I’m overheating,” Campbell, 41, said. “To break through that, it just feels clear.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

WSS

Vertex non

Health Care Service Corp to buy Cigna Medicare Advantage plans

Venture capital firm's plans to take over Akron hospital face hurdles

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

RSV shot was 90% effective at preventing hospitalizations in kids

Merck CEO won’t testify in Senate, citing no expertise in drug prices

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Supreme Court strikes down use of affirmative action

Amylyx ALS drug failure raises questions and concerns

Bright Health sells Medicare Advantage business to Molina

Change Healthcare cyberattack prompts Medicare loan program

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Anesthesiologist group: stop taking Ozempic before surgery

With psoriasis trial ahead, Alumis raises $259 million

Wikipedia

Sen. Paul opposes bill to ban Chinese biotechs

NEJM study link tiny plastics in blood vessels to heart problems

Amylyx ALS drug failure raises questions and concerns

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

The Readout: Amylyx, Alumis, and Lundbeck drug updates

Merck CEO won’t testify in Senate, citing no expertise in drug prices

hotspot

explore

focus

leisure time